Study S002805

A Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Study to Evaluate the Efficacy and Safety of HS-20094 in Overweight and Obese Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06839664
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: COMPLETED
Enrollment: 604
Start: 2024-11-16
Primary completion: 2026-01-04
Lead sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions: Overweight; Obesity
Interventions: DRUG:HS-20094 injection; DRUG:Placebo injection
Results posted: FALSE

Registered primary outcomes

Percent Change from Baseline in Body Weight [Baseline, week 48]
Percentage of Participants Who Achieve weight loss≥ 5% from Baseline [Baseline, week 48]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.